NEW YORK, NY / ACCESSWIRE / January 23, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Baxter International Inc. (BAX)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/baxter-international-inc-loss-submission-form?prid=5339&wire=1
Lead Plaintiff Deadline: January 24, 2020
Class Period: February 21, 2019 to October 23, 2019
Allegations against BAX include that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) the Company lacked effective internal control over financial reporting; (3) as a result, the Company's financial statements were misstated and would likely require correction or amendment; (4) due to the Company's internal investigation, Baxter would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on Form 10-Q in a timely manner; and (5) as a result of the foregoing, Defendants' statements about the Company's business and operations lacked a reasonable basis.
HEXO Corp. (HEXO)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/hexo-corp-loss-submission-form?prid=5339&wire=1
Lead Plaintiff Deadline: January 27, 2020
Class Period: January 25, 2019 to November 15, 2019
Allegations against HEXO include that: (1) HEXO's reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Portola Pharmaceuticals, Inc. (PTLA)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/portola-pharmaceuticals-inc-loss-submission-form?prid=5339&wire=1
Lead Plaintiff Deadline: March 16, 2020
Class Period: November 5, 2019 to January 9, 2020
Allegations against PTLA include that: (1) Portola's internal control over financial reporting regarding reserve for product returns was not effective; (2) Portola was shipping longer-dated product with 36-month shelf life; (3) Portola had not established adequate reserve for returns of prior shipments of short-dated product; (4) as a result, Portola was reasonably likely to need to "catch up" on accounting for return reserves; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more contact Vincent Wong, Esq. either via email firstname.lastname@example.org or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com: